| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/24/2005 | WO2004022699A3 Liquid stable composition of oxazaphosphorine with mesna |
| 03/24/2005 | WO2004018482A8 C6- and c9-substituted chromeno[4, 3-c]isoxazoline derivatives and their use as anti-depressants |
| 03/24/2005 | WO2004017972A8 Biologic skin repair and enhancement |
| 03/24/2005 | WO2004017948A8 Use of lck inhibitor for treatment of immunologic diseases |
| 03/24/2005 | WO2004016607A8 Inhibition of phosphoinositide 3-kinase beta |
| 03/24/2005 | WO2004012683A9 Novel druggable regions in set domain proteins and methods of using the same |
| 03/24/2005 | WO2004000197A3 Quick dissolve compositions and tablets based thereon |
| 03/24/2005 | WO2003101176A3 Method, composition and kit for antigenic binding of norwalk-like viruses |
| 03/24/2005 | WO2003099217A3 Methods of treating bacterial infections and diseases associated therewith |
| 03/24/2005 | WO2003097592A3 Treatment of age-related lung abnormalities using estrogen and/or retinoids |
| 03/24/2005 | WO2003083067A3 Histone deacetylase inhibitors for the treatment of multiple sclerosis, amyotrophic lateral sclerosis and alzheimer's disease |
| 03/24/2005 | WO2003082208A8 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders |
| 03/24/2005 | WO2003079970A8 4-(diarylmethyl)-1-piperazinyl derivatives |
| 03/24/2005 | WO2003045973A8 Peptides with growth inhibitory action |
| 03/24/2005 | WO2002058450A3 Regulation of cell growth by muc1 |
| 03/24/2005 | US20050065348 Pyridin-2-yl-methylamine derivatives for treating opioid dependence |
| 03/24/2005 | US20050065346 anticoagulants; thrombosis; factor x inhibitor |
| 03/24/2005 | US20050065343 Reacting 6-hydroxy-3,4-dihydroquinoline with 1-cyclohexyl-5-(halbutyl)tetrazole in presence of a base |
| 03/24/2005 | US20050065341 Substituted 8-heteroaryl xanthines |
| 03/24/2005 | US20050065340 Psychological disorders; anxiolytic agents; antidepressants; analgesics ; schizophrenia |
| 03/24/2005 | US20050065335 inhibiting complexation of intercalating molecules with polynucleotides; using modified xanthine molecules as a binding agent; drug delivery system for compounds that have low solubility in aqueous media, including anti-neoplastic agents |
| 03/24/2005 | US20050065319 Combination method for treating viral infections |
| 03/24/2005 | US20050065308 Mold inhibitor integrated within a matrix and method of making same |
| 03/24/2005 | US20050065219 Treatment of demyelinating conditions |
| 03/24/2005 | US20050065218 Metabolites; or synergistic mixture with imipramine or fluoxetine |
| 03/24/2005 | US20050065216 Therapy for multiple sclerosis, psoriasis, urticaria; antiarthritic agents; incotinence; antitumor, anticancer agents |
| 03/24/2005 | US20050065215 Thickened amine compound for dentistry, medicine; controlling viscosity |
| 03/24/2005 | US20050065214 Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects |
| 03/24/2005 | US20050065213 Anticancer agents; endometriosis; psoriasis; vision defects |
| 03/24/2005 | US20050065212 Use of at least one 10-hydroxy-2-decenoic acid derivative in compositions for treating the cuteous signs of aging |
| 03/24/2005 | US20050065209 Citalopram for the treatment of elevated blood pressure |
| 03/24/2005 | US20050065208 Benzofuranes and their use in the treatment of atrial fibrillation |
| 03/24/2005 | US20050065207 Method for the preparation of escitalopram |
| 03/24/2005 | US20050065206 Skin preparation comprising a tocopherol derivative for external application |
| 03/24/2005 | US20050065205 Administering protein kinase C activator such as macrocyclic lactone; mixture with enzyme inhibitor and carrier |
| 03/24/2005 | US20050065203 use of an angiotensin-converting enzyme inhibitor, ramipril, to reduce the decline of beta -cell function, increase islet blood flow, lower aldosterone secretion, lower renal potassium wasting, increase pancreatic beta -cell perfusion, reduce insulin resistance in skeletal muscles, |
| 03/24/2005 | US20050065202 Controlling appetites; dietetics; obesity; eating disorders; cachexia; antidiabetic agents |
| 03/24/2005 | US20050065201 Fungicides in human, animals; controlling plant diseases; reacting 1-(2,4-dichlorophenyl)-2-imidazol-1-yl-ethanol with halogen substituted benzthiophene compoundu |
| 03/24/2005 | US20050065199 Mixture of fungicide and 2,2'-dithiobis(pyridine-n-oxide) stabilizer |
| 03/24/2005 | US20050065198 Inhibitors of 15-lipoxygenase |
| 03/24/2005 | US20050065196 Azole compound and medicinal use thereof |
| 03/24/2005 | US20050065195 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 03/24/2005 | US20050065194 Moderation cellular gene expression; antiproliferative agents; anticancer agents |
| 03/24/2005 | US20050065193 Carbamates of 2-heterocyclic-1,2-ethanediols |
| 03/24/2005 | US20050065192 Synergistic mixture of methotrexate and integrin antigen or antibody |
| 03/24/2005 | US20050065191 Central nervous system disorders; therapy for diseases of glutamate receptor signal transmission |
| 03/24/2005 | US20050065190 Comprehensive pharmacologic therapy for treatment of obesity including cysteine |
| 03/24/2005 | US20050065189 Thiazole derivatives as cannabinoid receptor modulators |
| 03/24/2005 | US20050065187 Novel antimicrobial aryloxazolidinone compounds |
| 03/24/2005 | US20050065186 Heterocyclyloxy-, -thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/24/2005 | US20050065185 Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/24/2005 | US20050065184 Using angiotensin converting enzyme inhibitor; cardiovascular disorders; antidiabetic agentsd |
| 03/24/2005 | US20050065183 Bioavailability; mixture containing lactose and hydroxypropyl cellulose |
| 03/24/2005 | US20050065182 Method and compositions for chronic wound care |
| 03/24/2005 | US20050065180 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a growth hormone secretagogue |
| 03/24/2005 | US20050065178 Substituted diazabicycloakane derivatives |
| 03/24/2005 | US20050065176 Combinations |
| 03/24/2005 | US20050065175 Oral transmucosal methadone |
| 03/24/2005 | US20050065172 Micxture of caffeine and a cephalin; controlling particle size; high speed dissolving |
| 03/24/2005 | US20050065171 Therapy, prevention leukemia; antitumor agents |
| 03/24/2005 | US20050065170 Compounds |
| 03/24/2005 | US20050065169 Heteroaryl-fused pyrimidinyl compounds as anticancer agents |
| 03/24/2005 | US20050065167 6-Aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agents |
| 03/24/2005 | US20050065165 Method of treating certain cancers using an estrogen agonist/antagonist |
| 03/24/2005 | US20050065164 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| 03/24/2005 | US20050065163 Platelet adenosine diphosphate receptor antagonists |
| 03/24/2005 | US20050065162 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 03/24/2005 | US20050065159 Penis enlargement |
| 03/24/2005 | US20050065158 Using cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitor; sunergistic mixture with histamine h-3 antagonist |
| 03/24/2005 | US20050065157 Carbazole derivatives and their use as npy5 receptor antagonists |
| 03/24/2005 | US20050065156 Compounds useful as motilin agonists and method |
| 03/24/2005 | US20050065155 Autoimmune disease ; antiinflammatory agents; antiischemic agents; rheumatic diseases; antiarthritic agents |
| 03/24/2005 | US20050065154 Treatment of migraine accompanied by nausea with a combination of cyclooxygenase-2 selective inhibitors and anti-nausea agents |
| 03/24/2005 | US20050065153 Antiinflamamtory agents; respiratory system disorders; autoimmune disease |
| 03/24/2005 | US20050065152 1-Adamantyl chalcones for the treatment of proliferative disorders |
| 03/24/2005 | US20050065150 Lipoxygenase moderators; autoimmune disease; neurodegenerative disease; respiratory system disorders; cardiovascular disorders; Alzheimer's disease; Parkinson's disease; amyotropic lateral sclerosis |
| 03/24/2005 | US20050065149 Neurodegenerative disorders; antiinflammatory agents; strokes; antiischemic agents; neuropathic pain; brain disorders; antiepileptic agents; Parkinson's disease ; amyotropic lateral sclerosis; Alzheimer's disease; antidiabetic agents |
| 03/24/2005 | US20050065148 Dipeptidyl peptidase inhibitors |
| 03/24/2005 | US20050065147 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
| 03/24/2005 | US20050065146 Cognition activators; neurodegenerative diseases; anxiolytic agents;psychological disorders; alzheimer's disease; Huntington's disease; antiischemic agents; antiepileptic agenst |
| 03/24/2005 | US20050065144 Dipeptidyl peptidase inhibitors |
| 03/24/2005 | US20050065143 Pyridazine derivatives and their use as therapeutic agents |
| 03/24/2005 | US20050065142 Antidiabetic agents; therapy for insulin resistance |
| 03/24/2005 | US20050065141 Carbapenems useful in treating and preventing pulmonary infections, pharmaceutical compositions thereof and modes of administration thereof |
| 03/24/2005 | US20050065140 Antidepressant; side effect reduction |
| 03/24/2005 | US20050065139 Antidiabetic agents; controlling carbohydrate metabolism |
| 03/24/2005 | US20050065138 Acetone solvate of dimethoxy docetaxel and its process of preparation |
| 03/24/2005 | US20050065137 Triamcinolone acetonide and anecortave acetate formulations for injection |
| 03/24/2005 | US20050065136 Administering by mouth, transdermal; controlling concentration |
| 03/24/2005 | US20050065135 Contraceptives; side effect reduction; antitumor, anticancer agents |
| 03/24/2005 | US20050065134 2-aklylidene-19-nor-vitamin D derivatives for the treatment of anorexia or low bone mass in females exhibiting aggressive athletic behavior |
| 03/24/2005 | US20050065133 Synergistic mixture; bone disorders; osteoporosis ; anticancer agents; obesity |
| 03/24/2005 | US20050065132 Bone disorders |
| 03/24/2005 | US20050065131 Enhancing bone mass |
| 03/24/2005 | US20050065130 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a cyclooxgenase-2 inhibitor |
| 03/24/2005 | US20050065129 Muscular disorders |
| 03/24/2005 | US20050065128 Glandular disorders |
| 03/24/2005 | US20050065127 Bone disorders; anticarcinogenic agents |
| 03/24/2005 | US20050065126 Synergistic mixture; osteoporosis therapy; bone disorders; anticancer agents; obesity |
| 03/24/2005 | US20050065125 2-alkylidene-19-nor-vitamin D derivatives for the treatment of osteopenia or male osteoporosis |